Cargando…
Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy
Patients with myotonic dystrophy type 1 (DM1) identify chronic fatigue as the most debilitating symptom, which manifests in part as prolonged recovery after exercise. Clinical features of DM1 result from pathogenic gain-of-function activity of transcripts containing an expanded microsatellite CUG re...
Autores principales: | Hu, Ningyan, Kim, Eunjoo, Antoury, Layal, Li, Jia, González-Pérez, Paloma, Rutkove, Seward B., Wheeler, Thurman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787993/ https://www.ncbi.nlm.nih.gov/pubmed/33473325 http://dx.doi.org/10.1016/j.omtn.2020.11.014 |
Ejemplares similares
-
Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy
por: Hu, Ningyan, et al.
Publicado: (2023) -
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
por: Hu, Ningyan, et al.
Publicado: (2018) -
Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
por: Jauvin, Dominic, et al.
Publicado: (2017) -
Urine mRNA to identify a novel pseudoexon causing dystrophinopathy
por: Antoury, Layal, et al.
Publicado: (2019) -
Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
por: Antoury, Layal, et al.
Publicado: (2018)